BRIEF published on 05/14/2025 at 22:20, 8 months 22 days ago Bausch Health annonce les résultats des élections et les approbations lors de son assemblée annuelle 2025 Bausch Santé Vote Des Actionnaires Élection Du Directeur Assemblée Annuelle Approbation De L'indemnisation
BRIEF published on 05/14/2025 at 22:20, 8 months 22 days ago Bausch Health Announces Election Results and Approvals at 2025 Annual Meeting Bausch Health Annual Meeting Shareholder Vote Director Election Compensation Approval
PRESS RELEASE published on 05/14/2025 at 22:15, 8 months 22 days ago Bausch Health Announces 2025 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces election of 10 directors at 2025 annual meeting of shareholders and various approvals and appointments Shareholders Bausch Health Companies Inc. Compensation Annual Meeting Election Of Directors
BRIEF published on 05/06/2025 at 14:05, 8 months 30 days ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
BRIEF published on 05/06/2025 at 14:05, 8 months 30 days ago Xifaxan réduit le risque de réhospitalisation dans les 30 jours suivant une OHE XIFAXAN Maladie Chronique Du Foie Lactulose Réhospitalisation OHE Analyse Basée Sur Les Réclamations
PRESS RELEASE published on 05/06/2025 at 14:00, 8 months 30 days ago Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization New analysis shows Xifaxan efficacy in reducing OHE rehospitalizations regardless of prior treatment. Data presented at DDW 2025 XIFAXAN Bausch Health Gastroenterology OHE Rehospitalizations
BRIEF published on 04/30/2025 at 22:10, 9 months 5 days ago Bausch Health Reports First-Quarter 2025 Results Financial Results EBITDA Revenue Growth Bausch Health First Quarter 2025
BRIEF published on 04/30/2025 at 22:10, 9 months 5 days ago Bausch Health publie ses résultats du premier trimestre 2025 Résultats Financiers EBITDA Croissance Des Revenus Bausch Santé Premier Trimestre 2025
PRESS RELEASE published on 04/30/2025 at 22:05, 9 months 5 days ago Bausch Health Announces First Quarter 2025 Results Bausch Health Companies Inc. reports strong first quarter 2025 financial results with revenue growth, successful refinancing, and favorable court ruling. Company remains focused on profitable growth and shareholder value Financial Results Revenue Growth Shareholder Value Bausch Health First Quarter 2025
BRIEF published on 04/29/2025 at 14:05, 9 months 6 days ago Bausch Health Secures Health Canada Approval for Thermage FLX Thermage FLX Bausch Health Health Canada Aesthetic Technology Skin Tightening
Published on 02/06/2026 at 08:00, 1 hour 28 minutes ago Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 03:50, 5 hours 38 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 6 hours 43 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 8 hours 31 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 9 hours 28 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/06/2026 at 09:00, 27 minutes ago Original-Research: 123fahrschule SE (von NuWays AG): BUY
Published on 02/06/2026 at 08:00, 1 hour 27 minutes ago A stronger and more competitive Ørsted after a defining year with earnings of DKK 25.1 billion within guidance
Published on 02/06/2026 at 07:54, 1 hour 33 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
Published on 02/05/2026 at 19:15, 14 hours 13 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 14 hours 13 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
